poisar

Stocks · News reference

DNA X Says Expects Revenue From Trading Platform To Begin Towards End Of Q3 2026 Or Beginning Of Q4 2026

BenzingaAug 19, 2026, 8:21 PMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 19, 2026, 8:21 PM
Checked
Aug 19, 2026, 8:21 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARAug 27, 2026, 11:32 AMSEC EDGAR

    8-K filing — DNA X, Inc. (SONM)

    Filed: 2026-08-27 AccNo: 0001493152-26-040324 Size: 206 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

    Read original at edgar